Teva Pharmaceutical Industries (TEVA) Earnings Date, Estimates & Call Transcripts $18.45 +0.01 (+0.05%) (As of 11/1/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Teva Pharmaceutical Industries Latest Earnings SummaryUpcoming Q3 Earnings DateNov. 6Before Market OpensConfirmedActual EPS (Jul. 31) $0.58 Beat By $0.03 Consensus EPS (Jul. 31) $0.55 Teva Pharmaceutical Industries posted Q2 2024 earnings on July 31, 2024, reporting an EPS of $0.58, which beat analysts' consensus estimates of $0.55 by $0.03. Quarterly revenue was reported to be $4.16 billion, above analyst estimates of $3.99 billion. With a trailing EPS of -$0.39, Teva Pharmaceutical Industries' earnings are expected to grow 14.16% next year, from $2.33 to $2.66 per share. TEVA Upcoming EarningsTeva Pharmaceutical Industries' next earnings date is scheduled for Wednesday, November 6, 2024, with a conference call scheduled for at 8:00 AM ET. Interested parties can register for or listen to the call. Get Teva Pharmaceutical Industries Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Teva Pharmaceutical Industries and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTEVA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TEVA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade Teva Pharmaceutical Industries Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241$0.48$0.48$0.48 Q2 20241$0.56$0.56$0.56 Q3 20241$0.57$0.57$0.57 Q4 20241$0.67$0.67$0.67 FY 20244$2.28$2.28$2.28 Q1 20251$0.44$0.44$0.44 Q2 20251$0.58$0.58$0.58 Q3 20251$0.66$0.66$0.66 Q4 20251$0.83$0.83$0.83 FY 20254$2.51$2.51$2.51 Q1 20261$0.50$0.50$0.50 Q2 20261$0.64$0.64$0.64 Teva Pharmaceutical Industries Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/6/2024(Confirmed)------- 7/31/2024Q2 2024$0.55$0.58+$0.03$1.91$3.99B$4.16B5/8/2024Q1 2024$0.49$0.46 -$0.03$1.04$3.70B$3.82B 1/31/2024Q4 2023$0.73$0.98+$0.25$1.55$3.97B$4.46B 11/8/2023Q3 2023$0.57$0.60+$0.03$1.09$3.73B$3.90B 8/2/2023Q2 2023$0.52$0.54+$0.02$1.85$3.69B$3.88B 5/10/2023Q1 2023$0.55$0.37 -$0.18$0.92$3.60B$3.66B Get the Latest News and Ratings for TEVA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Teva Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter. 2/8/2023Q4 2022$0.64$0.68+$0.04$2.46$3.90B$3.88B 11/3/2022Q3 2022$0.58$0.56 -$0.02$1.07$3.86B$3.60B Teva Pharmaceutical Industries Earnings - Frequently Asked Questions When is Teva Pharmaceutical Industries's earnings date? Teva Pharmaceutical Industries has confirmed that its next quarterly earnings data will be published on Wednesday, November 6th, 2024. Learn more on TEVA's earnings history. Did Teva Pharmaceutical Industries beat their earnings estimates last quarter? In the previous quarter, Teva Pharmaceutical Industries (NYSE:TEVA) reported $0.58 earnings per share (EPS) to beat the analysts' consensus estimate of $0.55 by $0.03. Learn more on analysts' earnings estimate vs. TEVA's actual earnings. How much revenue does Teva Pharmaceutical Industries generate each year? Teva Pharmaceutical Industries (NYSE:TEVA) has a recorded annual revenue of $15.85 billion. How much profit does Teva Pharmaceutical Industries generate each year? Teva Pharmaceutical Industries (NYSE:TEVA) has a recorded net income of -$559 million. TEVA has generated -$0.39 earnings per share over the last four quarters. What is Teva Pharmaceutical Industries's price-to-earnings ratio? Teva Pharmaceutical Industries (NYSE:TEVA) has a forward price-to-earnings ratio of 7.92. The price/earnings-to-growth ratio is 1.33. What is Teva Pharmaceutical Industries's EPS forecast for next year? Teva Pharmaceutical Industries's earnings are expected to grow from $2.33 per share to $2.66 per share in the next year, which is a 14.16% increase. ` More Earnings Resources from MarketBeat Related Companies GSK Earnings Results TAK Earnings Results BNTX Earnings Results BGNE Earnings Results DNA Earnings Results MRNA Earnings Results GMAB Earnings Results SMMT Earnings Results VTRS Earnings Results RDY Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to RunBank of America Earnings Uncover Shifts in Consumer Spending Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad)WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade This page (NYSE:TEVA) was last updated on 11/3/2024 by MarketBeat.com Staff From Our PartnersThe Death Knell for U.S. StocksThey are among the 31 billionaires dumping their stocks at a record pace. Fortune calls this phenomenon "Th...InvestorPlace | SponsoredCharles Payne Wants You Prepared for Q4Charles Payne Wants You Prepared for Q4 Because as we look toward 2025, there's no denying that market vola...Unstoppable Prosperity | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teva Pharmaceutical Industries Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Teva Pharmaceutical Industries With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.